🔎 Trials Near Me

Akèy › Twoub depresif majè › Kalifòni › Los Angeles

Etid klinik pou Twoub depresif majè nan Los Angeles, CA

12 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Ap rekriteFaz 3
  • CalNeuro Research Group, Los Angeles
  • Lipov Medical Group, Los Angeles
Laj 18 a 85 · Tout sèks · Mizajou Oct 5, 2026 · NCT06793397

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Ap rekrite
  • USC University Hospital, Los Angeles
  • UCLA Department of Psychiatry, Los Angeles
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

Pain and Major Depressive Disorder

Ap rekriteMande peman pou patisipan yo
  • UCLA Semel Institute, Los Angeles
Laj 18 a 75 · Tout sèks · Mizajou Aug 11, 2026 · NCT04556890

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06963021

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • CalNeuro Research Group, Los Angeles
Laj 18 a 64 · Tout sèks · Mizajou Aug 3, 2026 · NCT06547489

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Ap rekriteFaz 3
  • CalNeuro Research Group, Inc., Los Angeles
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Ap rekriteFaz 3
  • Clinical Research Site, Los Angeles
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Evaluating tDCS Brain-stimulation in Depression Using MRI

Ap rekrite
  • University of California Los Angeles (UCLA), Los Angeles
Laj 20 a 55 · Tout sèks · Mizajou Jun 8, 2026 · NCT05598034

Regulation of Affect and Physiology in Depression

Ap rekriteFaz 2Volontè an sante akeyi
  • University of Southern California, Los Angeles
Laj 18 a 27 · Tout sèks · Mizajou May 4, 2026 · NCT06345859

In-patient SCC TMS

Ap rekrite
  • UCLA TMS Service and Research Service, Los Angeles
Laj 18 a 65 · Tout sèks · Mizajou Sep 23, 2025 · NCT05645575

Study of ALTO-300 in MDD

Ap rekriteFaz 2
  • Site 209, Los Angeles
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.